Intellectual Property India Publishes Patent Application for 'Cyclic Benzimidazole Derivatives As Cgas Inhibitors' Filed by Boehringer Ingelheim International Gmbh

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053818 A) filed by Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, Germany, on June 3, for 'cyclic benzimidazole derivatives as cgas inhibitors.'

Inventor(s) include Heimann, Annekatrin Charlotte; Dreyer, Alexander; Gnamm, Christian; Godbout, Cedrickx; Grundl, Marc Alexander; Handschuh, Sandra Ruth; Hoenke, Christoph; Kley, Joerg Thomas; Kuttruff, Christian Andreas; Li, Jun; Reinert, Dirk; and Stuber, Raphael.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The invention relates to compounds of formula I wherein R1, R2, R3, A, D, E, G, J, K and L are defined as in claim 1, and prodrugs, deuterated analogues and pharmaceutical acceptable salts thereof, for the treatment of diseases such as systemic lupus erythematosus, systemic sclerosis (SSc), interferonopathies, non-alcoholic steatohepatitis (NASH), interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF)."

The patent application was internationally filed on Nov. 03, 2023, under International application No.PCT/EP2023/080705.

Disclaimer: Curated by HT Syndication.